GERMANY: FORECAST FOR CHEMICAL INDUSTRY

Article Abstract:

Production of the German chemical industry is to grow about 2% in 1998, compared with 5% in 1997. According to a prognosis of Deutsche Bank Research, volume growth of the chemical sector is to amount to 2-3% in 1999, with exports remaining on a high level. Increased demand from the EU (50% of all exports) and NAFTA countries is to more than compensate the losses in Asia. Growth will be derived also from increased consumer spending in Germany. Thanks to a rising output, a continuous increase of productivity and declining costs because of decreasing oil prices, the chemical sector is to expect satisfying profit performances in 1998 and 1999. Concerning the pharmaceutical sector, Deutsche Bank Research expects output to grow by 3% in real terms in 1998. Exports are to rise at a two-digit rate. About two fifths of pharmaceuticals are exported, with Switzerland, Japan, the US, France, the UK and Italy accounting for 50% of all exports. In 1999, the production of pharmaceuticals is to rise by 4%. The market for generics, which account for 50% of the pharmaceuticals market of statutory health insurers, is to grow above average. Sales of OTC products are to increase as well. At present, OTC products have a share of 30% of the pharmacies' market.

Germany, Market information - general, Forecasts, trends, outlooks, Chemicals & Allied Products, Chemical Manufacturing, Chemicals

---

Teva kauft Pharmachemie

Article Abstract:

The Dutch pharmaceutical trading company OPG has sold its subsidiary Pharmachemie, which produces generic drugs in Haarlem and Zaandam, to Israel's biggest pharmaceutical producer Teva. The deal is worth Fl 175mn. With an annual turnover of Fl 250mn, Pharmachemie controls about 40% of the Dutch market. It will continue to supply pharmaceuticals to OPG, which is to concentrate on trade. *

Comment:

Sells Pharmachemie, generic drugs producer, to Israel's biggest pharmaceutical producer Teva for Fl175 mil

Acquisitions & mergers, Netherlands, Teva Pharmaceutical Industries Ltd., Article, Pharmachemie B.V., OPG

---

CZECH REPUBLIC: PLIVA TAKES OVER LACHEMA

Article Abstract:

The Czech pharmaceutical producer Lachema has been acquired two-thirds by Pliva. The leading Croatian drug producer paid US$ 26mn for the stake through its Polish Cracow-based subsidiary.

Czech Republic, Lachema, Pliva

Similar abstracts:

• Abstracts: GERMANY: NEW PAINT FACTORY FOR LACUFA. GERMANY/AUSTRIA: CERTIFIED PAINT QUALITY
• Abstracts: GERMANY: E-COMMERCE WITH BORCHERS. Switzerland: Reorganisation at Clariant. SWITZERLAND/JAPAN: EMS BETTING ON PRIMID
• Abstracts: BRAZIL/GERMANY: HEMMELRATH TO SET UP PLANT IN BRAZIL. US: FORECAST FOR PAINT MARKET GROWTH TO 2004. BRAZIL: GROWING DEMAND IN COATINGS MARKET
• Abstracts: FRANCE/GERMANY: JOB CUTS/RESTRUCTURING AT FUCHS. FRANCE: TOTAL RAFFINAGE TO ABSORB FINA FRANCE. France: Total Fina Elf takes in a new lubricant branch
• Abstracts: FRANCE: FFR 544MN INVESTMENT FOR NOVARTIS PHARMA. FRANCE: AVENTIS PHARMA INVESTS FFR 160MN IN LE TRAIT. FRANCE: BIRTH OF LORRAINE PHARMA

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.